RUC-4 Compound

DRUG2 trials

Sponsors

CeleCor Therapeutics

Conditions

Coronary DiseaseHeart DiseasesMyocardial InfarctionSTEMI - ST Elevation Myocardial InfarctionVascular Diseases

Phase 1

A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4

CompletedNCT03844191

CeleCor TherapeuticsCoronary Disease

Start: 2019-02-18End: 2019-12-01Updated: 2024-08-27

Phase 2

A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction

CompletedNCT04284995

CeleCor TherapeuticsCoronary Disease, Heart Diseases, Myocardial Infarction +2

Start: 2020-06-02End: 2020-12-14Updated: 2021-02-03